Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 16 October 2025

J.B. Hunt (JBHT) Stock Soars on Earnings Surprise – Is a Freight Sector Revival Underway?

J.B. Hunt (JBHT) Stock Soars on Earnings Surprise – Is a Freight Sector Revival Underway?

Stock Rally After Earnings Beat J.B. Hunt’s stock rallied hard on Oct. 16. Reuters reported that JBHT shares “rose nearly 16% in early trading on Thursday” (Oct 16) after the company’s cost-cutting drove a stronger-than-expected profitreuters.com. Traders noted a similar jump (about 18%) according to market news on StockTwitsstocktwits.com. The surge pushed JBHT to multi-week highs (roughly mid-$160s per share) as investors reacted to the Q3 results and upbeat comments from analysts. (For context, JBHT had closed around $138.83 on Oct. 15benzinga.com.) The broad market backdrop also helped: easing China trade worries and hopes for Fed rate cuts lifted U.S.
16 October 2025
·
Whitehawk Therapeutics Stock Rockets on AI Partnership – What Investors Need to Know

Whitehawk Therapeutics Stock Rockets on AI Partnership – What Investors Need to Know

Whitehawk’s stock popped dramatically on Oct. 16 after news of the Tempus collaboration. Shares had been around $2 per share in mid-Octoberstockinvest.us, but the new AI partnership sent them soaring in early trading. By mid-day Oct. 16, various data sites showed WHWK up roughly 50–67% on the sessioninvesting.com. (For comparison, it had already gained ~6.6% on Oct. 15stockinvest.usstocktitan.net.) The sudden jump reflects investor excitement about the Tempus deal, which was announced in a press release on Oct. 16marketscreener.com. The Tempus AI collaboration was officially billed as a “multi-year” partnership to use Tempus’s de-identified, multimodal clinical data to improve Whitehawk’s ADC
16 October 2025
Polestar Stock Skyrockets on Strong EV Sales and New Tech – What’s Next?

Polestar Stock Skyrockets on Strong EV Sales and New Tech – What’s Next?

Recent Stock Performance Polestar’s stock has been volatile in October 2025. After Q3 sales news on Oct. 9, PSNY climbed modestly (Reuters noted a ~+2% premarket risereuters.com), ending around $0.91 on Oct 15. By Oct 16 it was about $0.94investing.com. In contrast, the PSNYW warrants (which had languished at ~$0.20) saw a huge rally to ~$0.35 on Oct 16investing.com. Such warrant spikes often reflect speculative trading and have no immediate impact on company fundamentals, but they signal intense investor interest. StockAnalysis.com confirms PSNYW’s day gain of +76.6% to $0.36 on Oct 16stockanalysis.com. (PSNYW trading is thin and can move wildly.)
16 October 2025
··
United Airlines Stock Takes Off on Travel Boom and Record Revenue Forecast

United Airlines Stock Takes Off on Travel Boom and Record Revenue Forecast

Stock Performance and Recent Trends United’s stock has been climbing steadily heading into the earnings report. It closed around $104.18 on Oct. 15, up about 5% in just two days ts2.tech. This week’s rally built on a broader uptrend – shares have gained roughly 13% over the past quarter and nearly 45% year-on-year ts2.tech. Investors drove the stock higher in anticipation of strong results, aided by optimism across the airline sector. Notably, Delta’s upbeat earnings on Oct. 9 sent airline stocks higher, signaling that strength at one major carrier can lift the group ts2.tech. Market bulls argue that United’s emphasis
16 October 2025
·
Moderna’s Wild Ride: Vaccine Hopes Fuel Stock Pop Amid “One-Hit Wonder” Fears

Moderna’s Wild Ride: Vaccine Hopes Fuel Stock Pop Amid “One-Hit Wonder” Fears

Stock Rebounds on Moderna’s “Make-or-Break” Week Moderna’s stock is back in the spotlight after a turbulent week of news that sent the Nasdaq-listed shares swinging. On Wednesday, MRNA jumped over 5%, climbing to around $27.7 by market close marketbeat.com. The mini-rally came amid a flurry of developments – from upbeat trial data on a new cancer vaccine to analysts debating whether Moderna’s future is bright or bleak. Even after the pop, however, Moderna’s stock is a shadow of its former self: shares have cratered roughly 80% below last year’s levels marketbeat.com and are down one-third in 2025 alone. The once
16 October 2025
·
Theriva Biologics Stock Skyrockets 92% on Cancer Trial Breakthrough – What’s Next for TOVX?

Theriva Biologics Stock Skyrockets 92% on Cancer Trial Breakthrough – What’s Next for TOVX?

Recent Clinical Developments and Pipeline Updates Theriva Biologics – a Rockville, MD-based clinical-stage biotech – has made headlines with promising cancer trial results. On October 13, 2025, the company announced that expanded data from its VIRAGE Phase 2b trial in metastatic pancreatic ductal adenocarcinoma will be presented at the ESMO 2025 Congress on Oct. 20 ts2.tech. In this trial, patients receiving VCN-01 (an oncolytic adenovirus therapy) plus standard gemcitabine/nab-paclitaxel chemo showed markedly better outcomes than chemo alone. Interim data filed with the SEC reveal VCN-01 improved median overall survival to around 11–14 months versus ~8–11 months for chemo-only patients ts2.tech.
16 October 2025
LOBO EV Tech Rebrands & Sparks Trading Frenzy – What Investors Need to Know

LOBO EV Tech Rebrands & Sparks Trading Frenzy – What Investors Need to Know

Nasdaq Debut and Volatile Trading Lobo’s corporate makeover took effect on Oct. 16, when shareholders’ approval of a name change (dropping the “EV”) and a share reclassification became official tipranks.com. That morning, LOBO opened on Nasdaq at $0.86 and oscillated up to $0.97 before closing flat around $0.93 reuters.com. This frenetic trading came on unusually heavy volume, underscoring heightened interest around the rebrand. The Class A ordinary shares carry the same ticker “LOBO” but signal a new chapter for the company’s capital structure. Management framed the changes as a strategy to “enhance [LOBO’s] market presence” and reflect broader tech ambitions beyond just
16 October 2025
··
Marsh & McLennan’s Q3 Profit Jumps 11% Amid Rebrand to “Marsh” – What’s Next for MMC Stock?

Marsh & McLennan’s Q3 Profit Jumps 11% Amid Rebrand to “Marsh” – What’s Next for MMC Stock?

Q3 2025 Earnings: Solid Growth and an 11% Profit Jump Marsh & McLennan delivered a strong third quarter, topping expectations on both the top and bottom lines. Revenue reached $6.4 billion, up 11% from a year ago (4% on an underlying, constant-currency basis) stocktitan.net stocktitan.net. This was driven by double-digit growth in its core insurance broking unit and steady gains in consulting. The Risk & Insurance Services division (which includes its Marsh insurance brokerage and Guy Carpenter reinsurance arm) saw revenue surge +13% year-over-year to $3.9 billion stocktitan.net, boosted by firm insurance pricing earlier in the year and a rebound in client
16 October 2025
·
Axon Stock Plunges 8% Amid Market Rally – Analysts See Big Upside Ahead

Axon Stock Plunges 8% Amid Market Rally – Analysts See Big Upside Ahead

Axon Stock Sinks Despite Market Strength Axon shares suffered an unexpected jolt mid-week, falling over 8% in a single session – a steep one-day drop for a typically steady climber. The slide to $644.99 nasdaq.com on Wednesday came with no obvious bad news from the company. In fact, broader market conditions were positive: U.S. stocks rose on the same day on optimism about trade and interest rates ts2.tech. This made Axon’s decline stand out even more, as the stock vastly underperformed major indexes. Technical factors likely played a role. Axon’s plunge pushed it below its 200-day moving average (~$677) nasdaq.com,
16 October 2025
NuScale Stock Skyrockets on Historic SMR Deal – Can GE Vernova Catch Up in the Nuclear Boom?

NuScale Stock Skyrockets on Historic SMR Deal – Can GE Vernova Catch Up in the Nuclear Boom?

NuScale’s Historic SMR Deal Sparks a Nuclear Stock Rally NuScale Power’s stock is on fire after the company secured a massive 6 gigawatt SMR deployment program with the Tennessee Valley Authority (TVA) – “the largest SMR deployment in U.S. history,” according to NuScale ts2.tech. The deal, executed via NuScale’s ENTRA1 Energy venture, will see up to six 77 MWe modular reactors installed in TVA’s service area, enough to power ~4.5 million homes and dozens of data centers ts2.tech. Investors cheered the news: on October 13, SMR shares spiked ~14% intraday, and by mid-week the stock was trading around $55 – roughly 20% higher
16 October 2025
··
Duke Energy Stock Soars to Record High Amid Grid Modernization Boom – What’s Next?

Duke Energy Stock Soars to Record High Amid Grid Modernization Boom – What’s Next?

Record High on Robust Performance Duke Energy’s share price has been on a steady upswing, recently reaching a record high of $127.85 ph.investing.com. As of October 16, the stock hovers in the upper-$120s after a strong multi-week rally. It closed at $127.02 on Oct. 10 – then its highest level of 2025 ts2.tech – and pushed even higher in the following days. Year-to-date, Duke has returned roughly 15–20% ph.investing.com ts2.tech, dramatically outperforming the broader utilities sector. Over the past five years, Duke delivered about a 62% total return ts2.tech, handily beating many peer utilities and underscoring the company’s steady growth
16 October 2025
·
U.S. Bancorp Stock Soars on Earnings Beat, Dividend Hike, and New Crypto Push

U.S. Bancorp Stock Soars on Earnings Beat, Dividend Hike, and New Crypto Push

USB Stock Price & Recent Trends U.S. Bancorp’s stock (USB) is trading around $47 per share following the earnings news, up from roughly $46 before the report. The upbeat Q3 results sparked a ~3% jump in pre-market and early session trading chartmill.com, as investors reacted to the better-than-expected profit numbers. This marks a sharp reversal of the stock’s recent trajectory – over the past month USB had slid about 6% amid market-wide volatility and rising interest rates chartmill.com. Despite today’s pop, U.S. Bancorp shares remain roughly flat year-to-date, underperforming some rival banks. For instance, Wells Fargo’s stock has surged ~27%
16 October 2025
···
Micron (MU) Stock Hits Record Highs on AI Frenzy – Analysts See More Upside Ahead

Micron (MU) Stock Hits Record Highs on AI Frenzy – Analysts See More Upside Ahead

Stock Performance: AI Hype Sends Micron Soaring Micron’s share price momentum in 2025 has been extraordinary. As of October, the stock has more than doubled from January levels, vastly outperforming the S&P 500 and even many tech peers ts2.tech. The rally accelerated in late September and early October when Micron hit fresh record highs, peaking intraday above $196 and closing near $192 ts2.tech. This surge reflects both company-specific optimism and broader “AI mania” lifting the semiconductor sector ts2.tech. Investors have piled into AI-related stocks, and Micron – as a key supplier of memory for AI systems – has been a
16 October 2025
Fossil Group (FOSL) Stock’s Wild 2025 Ride: Skyrockets on Turnaround Hopes, Stumbles on Debt Fears

Fossil Group (FOSL) Stock’s Wild 2025 Ride: Skyrockets on Turnaround Hopes, Stumbles on Debt Fears

Fossil Stock’s Rollercoaster 2025 Performance Fossil Group’s stock has been on a wild ride in 2025, with dramatic swings that grabbed Wall Street’s attention. After years of decline, FOSL shares staged a comeback this year – up over 60% year-to-date, vastly outperforming the broader apparel/accessories sector Nasdaq. The rally hit a fever pitch in mid-October: on October 15, Fossil’s stock skyrocketed 41.5% in a single day, hitting $3.89 intraday (a multi-year high) and closing at $3.75 Stockinvest. This surge was seemingly out of nowhere, and traders scrambled to pinpoint the cause. As it turned out, a confluence of positive news
16 October 2025
·
BNY Mellon Stock Soars on Record Earnings – Will BK’s Rally Continue?

BNY Mellon Stock Soars on Record Earnings – Will BK’s Rally Continue?

BK Stock Price & Recent Performance BNY Mellon’s stock has been on a tear in 2025. Shares are hovering around $109 as of mid-October, after rallying about +40% over the past 12 months investing.com. Year-to-date, BK is up roughly +42%, vastly outperforming the S&P 500 and many peer banks. (For perspective, Wells Fargo is +27% YTD ts2.tech.) The stock notched a 52-week high of ~$110.87 recently finviz.com and sits near that peak. Over just the last week and month, BK gained ~2–3%, reflecting a steady uptrend finviz.com. This strength has come amid a broader financial sector rebound. U.S. bank stocks
16 October 2025
·
Charles Schwab Stock Surges on Blowout Q3 Results, Analysts Eye More Upside

Charles Schwab Stock Surges on Blowout Q3 Results, Analysts Eye More Upside

Schwab’s Q3 results illustrate a strong growth cycle: client assets are growing at a record pace and fee & trading revenues are robust. As Wurster put it, this reflects “strengthening organic growth trends” and “favorable macroeconomic tailwinds” powering another “quarter of record revenue and earnings per share”pressroom.aboutschwab.com. With analysts updating ratings upward (as detailed by Benzinga and Capital.com) and the stock trading near multi-year highs, the near-term outlook for SCHW is widely seen as upbeatbenzinga.comcapital.com. Investors will watch closely how this wealth-gathering momentum holds up if market conditions change. Sources: Company filings and press release (Oct. 16 2025)pressroom.aboutschwab.compressroom.aboutschwab.com; MarketBeat and Benzinga earnings
16 October 2025
·
Linkage Global (LGCB) Stock Doubles on Funding Lifeline – Can the E-Commerce Underdog Sustain the Rally?

Linkage Global (LGCB) Stock Doubles on Funding Lifeline – Can the E-Commerce Underdog Sustain the Rally?

Stock Price Volatility Amid Funding News Linkage Global’s stock has been on a rollercoaster, catapulting upward in recent sessions. On Thursday Oct. 16, LGCB nearly doubled in pre-market action, reaching around $3 per share stockanalysis.com. This spike followed an after-hours leap the prior evening, catching traders’ attention as one of the top gainers on the market’s momentum radar chartmill.com. Such extreme volatility is not unprecedented for LGCB – just days earlier, the thinly traded stock had also spiked over 100% intraday to ~$3.33 before pulling back rttnews.com. The sudden rallies appear to be driven by speculative enthusiasm around the company’s
16 October 2025
·
Praxis Precision (PRAX) Stock Skyrockets on Game-Changing Phase 3 Results – What Experts Say

Praxis Precision (PRAX) Stock Skyrockets on Game-Changing Phase 3 Results – What Experts Say

Market Outlook With the stock now trading well above $150, investors are debating how much further PRAX could rise. If ulixacaltamide wins approval, analysts believe it could capture a sizable ET market. However, success in neurology trials can be binary – failures or setbacks could send the stock sharply down. Looking ahead, Praxis expects more data by late 2025/early 2026 (e.g. vormatrigine POWER1 topline, PRAX-562 EMBOLD readoutnasdaq.comneurologylive.com). Management’s guidance (via press releases and presentations) has focused on these milestones rather than concrete revenue forecasts, which is typical for clinical-stage biotechsnasdaq.com. In the near term, analysts will scrutinize FDA feedback and
16 October 2025
··
Nestlé Shares Soar 8% on Surprise Q3 Sales, 16,000-Job Cut Plan – What’s Next?

Nestlé Shocks Investors: 8% Stock Rally After Blowout Q3 and 16,000 Jobs on the Line

Key Facts: Nestlé’s stock jumped about 8% on Oct. 16 – its steepest one-day gain since 2008swissinfo.chts2.tech. That followed a surprise 4.3% rise in Q3 organic sales (versus ~3.7% expected)reuters.com, with its volume metric (real internal growth) at +1.5% (far above the +0.3% forecast)reuters.com. New CEO Philipp Navratil announced a costly “turnaround” plan: 16,000 job cuts (roughly 6% of the global workforce) over two yearsswissinfo.chtheguardian.com and an increased cost-savings goal of CHF 3.0 billion by 2027swissinfo.chtheguardian.com. Navratil said “the world is changing, and Nestlé needs to change faster,” warning that “hard but necessary” job cuts are comingswissinfo.ch. Analysts cheered the
16 October 2025
··
Bitdeer Stock Skyrockets 30% on Bitcoin Boom and AI Pivot – Analysts See More Upside

Bitdeer Stock Skyrockets 30% on Bitcoin Boom and AI Pivot – Analysts See More Upside

Bitdeer’s Stock Soars on Crypto & AI Momentum Shares of Bitdeer Technologies Group have been on a tear, skyrocketing 28–30% in a single day amid a perfect storm of positive catalysts wealthdaily.com coindesk.com. On October 15, BTDR surged from the low $20s to an intraday high of about $27.80, marking a new peak since the company’s spring 2023 Nasdaq listing theminermag.com. The rally was fueled by blowout operational results and a bold expansion into AI infrastructure, coupled with Bitcoin’s broader price boom. By mid-day, Bitdeer stock was still up ~26% around $25–26 ts2.tech, with trading volume exploding to 24.7 million
16 October 2025
·
1 … 1,118 1,119 1,120 1,121 1,122 … 1,172

Stock Market Today

Palantir stock price rebounds after AI shakeout — what traders watch next week

Palantir stock price rebounds after AI shakeout — what traders watch next week

7 February 2026
Palantir Technologies shares rose 4.5% to $135.90 Friday after reporting a 70% jump in Q4 revenue to $1.407 billion and forecasting 61% revenue growth in 2026. The stock rebounded from a 6.8% drop Thursday, triggered by concerns over Big Tech capital spending and AI’s impact on software demand. A new partnership with Cognizant and U.S. government policy shifts kept Palantir in focus. Director Alexander D. Moore sold 20,000 shares on Feb. 2.
Coca-Cola stock price ends near $79 — frozen products exit sets up KO earnings week

Coca-Cola stock price ends near $79 — frozen products exit sets up KO earnings week

7 February 2026
Coca-Cola will discontinue its frozen products, including the Minute Maid frozen line, in the U.S. and Canada in Q1 2026. Shares closed Friday up 0.66% at $79.03 ahead of Tuesday’s quarterly results. CEO James Quincey sold 337,824 shares on Feb. 3 for about $26 million under a pre-arranged plan. Options pricing suggests a possible 3% move after earnings.
Cisco stock jumps 3% into earnings week as tech shakeout keeps CSCO in focus

Cisco stock jumps 3% into earnings week as tech shakeout keeps CSCO in focus

7 February 2026
Cisco shares closed up 3% at $84.82 Friday after a volatile week for tech stocks. The company will report quarterly results Feb. 11, with analysts expecting EPS of $1.02 on $15.12 billion revenue. U.S. jobs and inflation data, delayed by the federal shutdown, are also due next week. About 23.9 million Cisco shares traded Friday.
Go toTop